SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Sex-Dependent Effects of CSF1R-Mediated Myeloid Cell Depletion in a Mouse Model of Multiple System Atrophy.

Eur J Neurosci · 2026-06-01

DOI: 10.1111/ejn.70586PMID: 42315936

Open accessbrief-report; Research Support, Non-U.S. Gov't; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Sex-dependent differences in neurodegenerative disorders are becoming increasingly relevant in diagnosis and development of therapeutic targets. Although multiple system atrophy (MSA), a devastating and rapidly progressing atypical parkinsonian disorder, is distributed equally among sexes, sex-specific differences have been reported regarding autonomic dysfunctions, severity of motor symptoms, and survival rate, suggesting a need for sex-specific treatment approaches. Neuroinflammation is a prominent hallmark in MSA pathology. Distinct activation patterns and increased phagocytosis of central nervous system (CNS) myeloid cells were observed, indicating a damaging role in this disease. In our previous study, we showed that colony-stimulating factor 1 receptor (CSF1R)-mediated depletion of myeloid cells in a mouse model of MSA led to a two-faced outcome, comprised of a prolonged survival and delayed onset of neurological dystonia-like symptoms, but also an aggravated motor phenotype and loss of dopaminergic neurons. Here, we re-analyzed our previous findings to study sex-specific effects in MSA in the presence and absence of CNS myeloid cells. Intriguingly, myeloid cell depletion was initially more effective in male animals. Although no sex-specific effects were detected in motor behavior, the occurrence of dystonia-like neurological symptoms was reduced, and neuronal loss was alleviated in male animals. Together, our findings provide insight into sex-specific differences of CSF1R-mediated myeloid cell depletion in MSA, emphasizing the need to study sex-specific treatment strategies in neurodegenerative disorders.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.